参考文献/References:
[1] Davila R E,Faigel D O.GI stromal tumors[J].Gastrointestinal Endosc,2003,58(1):80-88.
[2] Slow S L,Mahendran H A,Wong C M.Laparoscopic transgastric resection for intraluminal gastric gastrointestinal stromal tumors located at the posterior wall and near the gastroesophageal junction[J].Asian J Surg,2017,40(5):407-414.
[3] Kim M N,Kang S J,Kim S G,et al.Prediction of risk of malignancy of gastrointestinal stromal tumors by endoscopic ultrasonography[J].Gut Liver,2013,7(6):642-647.
[4] Hidetaka Y,Yoshinao O.Gastrointestinal stromal tumor: recent advances in pathology and genetics[J]. Pathology international,2015,65(1):9-18.
[5] Steinert D M,McAuliffe J C,Trent J C.Imatinib mesylate in the treatment of gastrointestinal stromal tumour[J].Expert Opin Pharmacother,2005,6(1):105-113.
[6] Mnif S M,Nacef L,Zghal I,et al.Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-a population-based study in western Sweden[J].Cancer,2010,103(4):821-829.
[7] Mucciarini C,Rossi G,Bertolini F,et al.Incidence and clinicopathologic features of gastrointestinal stromal tumors.A Population-Based Study[J].BMC Cancer,2007,7(1):230.
[8] Miettinen M,Lasota J,Sobin L H.Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the Literature [J].Am J Surg Pathol,2005,29(10):1373-1381.
[9] Luo X F,Zhuo L H.Prognostic significance of neutrophil to lymphocyte ratio in patients with gastrointestinal stromal tumors: A meta-analysis[J].Clin Chim Acta,2018,477:7-12.
[10] Rutkowski P,Teterycz P,Klimczak A,et al.Blood neutrophil-to-lymphocyte ratio is associated with prognosis in advanced gastrointestinal stromal tumors treated with imatinib[J].Tumori,2018,104(6):415-422.
[11] Kargin S,?kir M,Gündes E,et al.Relationship of preoperative neutrophil lymphocyte ratio with prognosis in gastrointestinal stromal tumors[J]. Ulus Cerrahi Derg,2015,31(2): 61-64.
[12] Hwang K T,Chung J K,Roh E Y,et al.Prognostic Influence of Preoperative Fibrinogen to Albumin Ratio for Breast Cancer[J].J Breast Cancer,2017,20(3):254-263.
[13] Xu Q D,Yan Y C,Gu S G,et al.A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma [J].J Immunology Res,2018,2018:4925498.
[14] Matsuda S,Takeuchi H,Kawakubo H,et al.Cumulative Prognostic Scores Based on Plasma Fibrinogen and Serum Albumin Levels in Esophageal Cancer Patients Treated with Transthoracic Esophagectomy: Comparison with the Glasgow Prognostic Score[J].Ann Surg Oncol,2015,22(1):302-310.
[15] Muenst S,Thies S,Went P,et al.Frequency, phenotype, and genotype of minute gastrointestinal stromal tumors in the stomach: an autopsy study[J].Hum Pathol,2011,42(12): 1849-1854.
[16] Tateishi U,Hasegawa T,Satake M,et al.Gastrointestinal stromal tumor.correlation of computed tomography findings with tumor grade and mortality [J].J Comput Assist Tomogr,2003,27(5):792-798.
[17] 沈琳,曹晖,秦叔逵,等.中国胃肠间质瘤诊断治疗共识(2017年版)[J].肿瘤综合治疗电子杂志,2018,1:31-43.
[18] Lee S E,Lee J H,Ryu K,et al.Preoperative Plasma Fibrinogen Level Is a Useful Predictor of Adjacent Organ Involvement in Patients with Advanced Gastric Cancer[J].J Gastric Cancer,2012,12(2): 81-87.
[19] Takeuchi H,Ikeuchi S,Kitagawa Y,et al.Pretreatment Plasma Fibrinogen Level Correlates With Tumor Progression and Metastasis in Patients With Squamous Cell Carcinoma of the Esophagus[J].J Gastroenterol Hepatol,2007,22(12):2222-2227.
[20] Son H,Park J W,Chang H J,et al.Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis; in patients with nonmetastatic colon cancer[J].Ann Surg Oncol,2013,20(9):2908-2913.
[21] Stephan P,Veronika S,Katrin H F,et al.Fibrinogen plasma levels are an independent prognostic parameter in patients with cervical cancer[J].Am J Obstet Gynecol,2009,200(6):647.e1-e7.
[22] Lu J,Chen S,Li X,et al.Gastrointestinal stromal tumors: Fibrinogen levels are associated with prognosis of patients as blood-based biomarker[J].Medicine(Baltimore),2018,97(17):e0568.
[23] Tan Z,Zhang M,Han Q,et al.A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the Fibrinogen/Albumin Ratio[J].J Cancer,2017,8(6):1025-1029.